Greater China Metabolic and Bariatric Surgery Database

Summary

Metabolic surgery, as a recognition treatment option for patients with clinical morbid obesity, is gaining increasing appreciation. In addition to substantial weight loss, emerging studies have highlighted that metabolic surgery can substantially ameliorate obesity-related metabolic diseases, including but not limited to type 2 diabetes mellitus (T2DM), hypertension, dyslipidemia, obstructive sleep apnea-hypopnea syndrome (OSAHS) and polycystic ovary syndrome (PCOS)in severely obese patients. However, further investigations with larger sample size and longer observation time still needed to clarity the efficacy and safety of metabolic surgery in Chinese patients with obesity and encouraging future research in this field.

Conditions

• Metabolic Surgery

Sponsors & Collaborators

• Beijing Tiantan Hospital

  collaborator OTHER

• Beijing Shijitan Hospital, Capital Medical University

  collaborator OTHER

• Beijing Hospital

  collaborator OTHER_GOV

• Peking Union Medical College Hospital

  collaborator OTHER

• Shanxi Dayi Hospital

  collaborator OTHER

• The Second Hospital of Hebei Medical University

  collaborator OTHER

• Tianjin Medical University General Hospital

  collaborator OTHER

• Inner Mongolia People's Hospital

  collaborator OTHER

• Henan Provincial People's Hospital

  collaborator OTHER

• Qilu Hospital of Shandong University

  collaborator OTHER

• The First Hospital of Hebei Medical University

  collaborator OTHER

• The Second People's Hospital of Xinxiang Henan

  collaborator UNKNOWN

• Tangshan Gongren Hospital

  collaborator OTHER

• Tianjin Nankai Hospital

  collaborator OTHER

• Tianjin First Central Hospital

  collaborator OTHER

• Beijing Friendship Hospital

  lead OTHER

Eligibility

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2018-04-01

Primary Completion

2028-04-01

Completion

2029-04-01

Countries

• China

Study Locations